Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shen-Sui-Tong-Zhi Formula (SSTZF) is a traditional Chinese medicine (TCM) herbal formulation that has been used for decades to treat osteoporosis and related bone disorders. It is composed of multiple herbs and is reported to enhance bone formation and inhibit bone resorption. Preclinical studies suggest SSTZF acts by modulating osteoblast and osteoclast activity, potentially through regulation of signaling pathways involved in bone metabolism[1]. The exact composition may vary but typically includes classic TCM ingredients aimed at nourishing the kidney and strengthening bones according to TCM theory.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on shen-sui-tong-zhi formula.